Skip to Main content Skip to Navigation
Journal articles

Capacity Building in Sub-Saharan Africa as Part of the INTENSE-TBM Project During the COVID-19 Pandemic

E. Ariza-Vioque 1 F. Ello 2 H. Andriamamonjisoa 3 V. Machault 4 J. Gonzalez-Martin 5, 6, 7 M. C. Calvo-Cortes 8 Serge Paul Eholie 9 G. A. Tchabert 2 T. Ouassa 10 M. Raberahona 11, 12, 13 R. Rakotoarivelo 14, 15 H. Razafindrakoto 11 L. Rahajamanana 11 R. J. Wilkinson 16, 17, 18 A. Davis 16 M. Maxebengula 16 F. Abrahams 16 C. Muzoora 19 N. Nakigozi D. Nyehangane D. Nanjebe H. Mbega R. Kaitano M. Bonnet 20 P. Debeaudrap 20 J. M. Miro 1, 7, 5 Xavier Anglaret 4, 2 N. Rakotosamimanana 3 A. Calmy 21, 22 Fabrice Bonnet 22, 4, 23 J. Ambrosioni 1, 7, 5 
Abstract : Tuberculous meningitis (TBM) is the most severe and disabling form of tuberculosis (TB), with at least 100,000 cases per year and a mortality rate of up to 50% in individuals co-infected with human immunodeficiency virus type 1 (HIV-1). To evaluate the efficacy and safety of an intensified anti-tubercular regimen and an anti-inflammatory treatment, the INTENSE-TBM project includes a phase III randomised clinical trial (TBM-RCT) in four countries in sub-Saharan Africa (SSA). Within this framework, we designed a comprehensive capacity-building work package ensuring all centres had, or would acquire, the ability to conduct the TBM-RCT and developing a network of skilled researchers, clinical centres and microbiology laboratories. Here, we describe these activities, identify strengths/challenges and share tools adaptable to other projects, particularly in low- and lower-middle income countries with heterogeneous settings and during the coronavirus disease 2019 (COVID-19) pandemic. Despite major challenges, TBM-RCT initiation was achieved in all sites, promoting enhanced local healthcare systems and encouraging further clinical research in SSA. In terms of certified trainings, the achievement levels were 95% (124/131) for good clinical practice, 91% (39/43) for good clinical laboratory practice and 91% (48/53) for infection prevention and control. Platform-based research, developed as part of capacity-building activities for specific projects, may be a valuable tool in fighting future infectious diseases and in developing high-level research in Africa.
Complete list of metadata
Contributor : Oskar Admin Connect in order to contact the contributor
Submitted on : Wednesday, July 13, 2022 - 2:06:38 PM
Last modification on : Friday, August 5, 2022 - 2:44:08 PM


Publisher files allowed on an open archive


Distributed under a Creative Commons Attribution - NonCommercial 4.0 International License



E. Ariza-Vioque, F. Ello, H. Andriamamonjisoa, V. Machault, J. Gonzalez-Martin, et al.. Capacity Building in Sub-Saharan Africa as Part of the INTENSE-TBM Project During the COVID-19 Pandemic. Infectious Diseases and Therapy, Springer Verlag, In press, ⟨10.1007/s40121-022-00667-z⟩. ⟨hal-03722476⟩



Record views


Files downloads